BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38616240)

  • 1. Adjuvant Role of Glucagon-Like Peptide-1 Receptor Agonist-Based Therapies for Sustained Weight Loss in Post-bariatric Surgery Patients.
    Dutta D; Nagendra L; Joshi A; Krishnasamy S; Sharma M; Parajuli N
    Obes Surg; 2024 Jun; 34(6):2261-2262. PubMed ID: 38616240
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review.
    Dréant A; Blanchard C; Jacobi D
    Obes Surg; 2024 May; 34(5):1846-1854. PubMed ID: 38436920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.
    Tang T; Abbott S; le Roux CW; Wilson V; Singhal R; Bellary S; Tahrani AA
    Diabetes Obes Metab; 2018 Mar; 20(3):745-748. PubMed ID: 29053203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective weight loss after treatment with a glucagon-like peptide-1 receptor agonist in a morbidly obese and diabetic patient before bariatric surgery: a case report.
    Chen JH; Tang WH; Lee CH
    J Med Case Rep; 2014 Sep; 8():304. PubMed ID: 25213589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Need for Sustained GLP-1 Agonist Therapy: a Perspective on Weight Regain After Bariatric Surgery.
    Chang PC; Huang YW; Huang CK; Chang TW
    Obes Surg; 2024 Jun; 34(6):2259-2260. PubMed ID: 38619774
    [No Abstract]   [Full Text] [Related]  

  • 6. The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.
    Lautenbach A; Wernecke M; Huber TB; Stoll F; Wagner J; Meyhöfer SM; Meyhöfer S; Aberle J
    Obes Surg; 2022 Oct; 32(10):3280-3288. PubMed ID: 35879524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
    Jensen AB; Renström F; Aczél S; Folie P; Biraima-Steinemann M; Beuschlein F; Bilz S
    Obes Surg; 2023 Apr; 33(4):1017-1025. PubMed ID: 36765019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.
    Dutta D; Nagendra L; Joshi A; Krishnasamy S; Sharma M; Parajuli N
    Obes Surg; 2024 May; 34(5):1653-1664. PubMed ID: 38502519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 Receptor Agonists in Weight Loss and Bariatric Surgery: Balancing Efficacy and Gastrointestinal Adverse Events.
    Au K; Yang W
    Obes Surg; 2024 Apr; 34(4):1382-1383. PubMed ID: 38198099
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery.
    Cummings DE; Overduin J; Shannon MH; Foster-Schubert KE;
    Surg Obes Relat Dis; 2005; 1(3):358-68. PubMed ID: 16925248
    [No Abstract]   [Full Text] [Related]  

  • 11. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta-analysis.
    Sarma S; Palcu P
    Obesity (Silver Spring); 2022 Nov; 30(11):2111-2121. PubMed ID: 36321278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology of weight loss surgery.
    Park CW; Torquati A
    Surg Clin North Am; 2011 Dec; 91(6):1149-61, vii. PubMed ID: 22054145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes.
    Ejarque M; Guerrero-Pérez F; de la Morena N; Casajoana A; Virgili N; López-Urdiales R; Maymó-Masip E; Pujol Gebelli J; Garcia Ruiz de Gordejuela A; Perez-Maraver M; Pellitero S; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Sci Rep; 2019 Apr; 9(1):6274. PubMed ID: 31000783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery.
    Iglesias P; Civantos S; Vega B; Pavón I; Guijarro G; Monereo S
    Obes Surg; 2015 Mar; 25(3):575-8. PubMed ID: 25589020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bariatric surgery on gut hormones that alter appetite.
    Pournaras DJ; Le Roux CW
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):508-12. PubMed ID: 20152735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium.
    Tam CS; Berthoud HR; Bueter M; Chakravarthy MV; Geliebter A; Hajnal A; Holst J; Kaplan L; Pories W; Raybould H; Seeley R; Strader A; Ravussin E
    Obes Rev; 2011 Nov; 12(11):984-94. PubMed ID: 21729236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study.
    Ilanga M; Heard JC; McClintic J; Lewis D; Martin G; Horn C; Khorgami Z; Richards J; Chow GS; Lim RB
    Surg Endosc; 2023 Dec; 37(12):9509-9513. PubMed ID: 37700013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.
    Mok J; Adeleke MO; Brown A; Magee CG; Firman C; Makahamadze C; Jassil FC; Marvasti P; Carnemolla A; Devalia K; Fakih N; Elkalaawy M; Pucci A; Jenkinson A; Adamo M; Omar RZ; Batterham RL; Makaronidis J
    JAMA Surg; 2023 Oct; 158(10):1003-1011. PubMed ID: 37494014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery.
    Borges-Canha M; Neves JS; Mendonça F; Silva MM; Costa C; M Cabral P; Guerreiro V; Lourenço R; Meira P; Salazar D; Ferreira MJ; Pedro J; Barkoudah E; Sande A; Lau E; B Souto S; Preto J; Freitas P; Carvalho D
    Front Endocrinol (Lausanne); 2021; 12():714173. PubMed ID: 34456871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ; De Flines J; De Roover A; Paquot N
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.